p130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53
Open accessAbstract
p53 represses the transcription of cdc2 and cyclin B1, causing loss of Cdc2 activity and G(2) arrest. Here we show that the region -22 to -2 of the cdc2 promoter called the R box is required for repression by p53 but not for basal promoter activity. The R box confers p53-dependent repression on heterologous promoters and binds to p130/E2F4 in response to overexpression of p53. R box-dependent repression requires p21/waf1, and overexpression of p21/waf1 also represses the cdc2 promoter. These observations suggest that p53 represses the cdc2 promoter by inducing p21/waf1, which inhibits cyclin-dependent kinase activity, enhancing the binding of p130 and E2F4, which together bind to and repress the cdc2 promoter.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
p130 and E2F4 are recruited to cell cycle gene promoters when p21 is activated by p53.
“Consistent with this notion, p130 and E2F4 are recruited to cell cycle gene promoters when p21 is activated by p53.98, 99”
From Census and evaluation of p53 target genes (2017) · cites this paper as [98]
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589 · see citing works
Molecular cloning: A laboratory manual
Deininger, P. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,684 · see citing works
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · see citing works
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693 · see citing works
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651 · see citing works
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761 · see citing works
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691 · see citing works
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017 · see citing works
Universal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,882 · see citing works
Requirement for p53 and p21 to Sustain G <sub>2</sub> Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · see citing works
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465 · see citing works
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341 · see citing works
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322 · see citing works
The complexity of p53 modulation: emerging patterns from divergent signalsPreprint
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,303 · see citing works
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251 · see citing works
Retinoblastoma protein recruits histone deacetylase to repress transcription
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,231 · see citing works
Rb Interacts with Histone Deacetylase to Repress Transcription
Luo, R. X., Postigo, A. A., & Dean, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)80940-x · Cited by 957 · see citing works
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895 · see citing works
Agarwal, M. L., Agarwal, A., Taylor, W. R., & Stark, G. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8493 · Cited by 858 · see citing works
Self-citationUncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1996) · Nature · doi:10.1038/381713a0 · Cited by 728 · see citing works
Agarwal, M. L., Taylor, W. R., Chernov, M. V., Chernova, O. B., & Stark, G. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.1 · Cited by 725 · see citing works
Self-citationInactivation of the p34 cdc2 -Cyclin B Complex by the Human WEE1 Tyrosine Kinase
Parker, L. L., & Piwnica-Worms, H. M. (1992) · Science · doi:10.1126/science.1384126 · Cited by 719 · see citing works
Recruitment of p300/CBP in p53-Dependent Signal Pathways
Avantaggiati, M. L., Ogryzko, V. V., Gardner, K., Giordano, A., Levine, A. S., & Kelly, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80304-9 · Cited by 668 · see citing works
Retinoblastoma protein switches the E2F site from positive to negative element
Weintraub, S. J., Prater, C. A., & Dean, D. C. (1992) · Nature · doi:10.1038/358259a0 · Cited by 657 · see citing works
A novel cyclin associates with M015/CDK7 to form the CDK-activating kinase
Fisher, R. P., & Morgan, D. O. (1994) · Cell · doi:10.1016/0092-8674(94)90535-5 · Cited by 655 · see citing works
GADD45 induction of a G <sub>2</sub> /M cell cycle checkpoint
Wang, X. W., Zhan, Q., Coursen, J. D., Khan, M. A., Kontny, H. U., Yu, L., Hollander, M. C., O’Connor, P. M., Fornace, A. J., & Harris, C. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3706 · Cited by 634 · see citing works
Analysis of Chromatin Structure byin VivoFormaldehyde Cross-Linking
Orlando, V., Strutt, H. L., & Paro, R. (1997) · Methods · doi:10.1006/meth.1996.0407 · Cited by 607 · see citing works
Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein
Lopez‐Girona, A., Furnari, B. A., Mondésert, O., & Russell, P. R. (1999) · Nature · doi:10.1038/16488 · Cited by 574 · see citing works
Cyclins and cyclin-dependent kinases: a biochemical view
Pines, J. (1995) · Biochemical Journal · doi:10.1042/bj3080697 · Cited by 538 · see citing works
Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.
McGowan, C. H., & Russell, P. R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05633.x · Cited by 495 · see citing works
Zhan, Q., Antinore, M. J., Wang, X. W., Carrier, F., Smith, M. L., Harris, C. C., & Fornace, A. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202667 · Cited by 474 · see citing works
Murphy, M. E., Ahn, J., Walker, K. K., Hoffman, W. H., Evans, R. M., Levine, A. J., & George, D. L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2490 · Cited by 455 · see citing works
Regulation of the human WEE1Hu CDK tyrosine 15‐kinase during the cell cycle.
Watanabe, N., Broome, M. R., & Hunter, T. R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07180.x · Cited by 450 · see citing works
p53 Transcriptional Activation Mediated by Coactivators TAF II 40 and TAF II 60
Thut, C. J., Chen, J.-L., Klemm, R. D., & Tjian, R. (1995) · Science · doi:10.1126/science.7809597 · Cited by 439 · see citing works
p53 regulates a G 2 checkpoint through cyclin B1
Innocente, S. A., Abrahamson, J., Cogswell, J. P., & Lee, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2147 · Cited by 435 · see citing works
CDC5 and CKII Control Adaptation to the Yeast DNA Damage Checkpoint
Toczyski, D. P., Galgoczy, D. J., & Hartwell, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80375-x · Cited by 431 · see citing works
Hurford, R. K., Cobrinik, D., Lee, M. H., & Dyson, N. (1997) · Genes & Development · doi:10.1101/gad.11.11.1447 · Cited by 431 · see citing works
Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway
Chaturvedi, P., Eng, W.-K., Zhu, Y., Mattern, M. R., Mishra, R., Hurle, M. R., Zhang, X., Annan, R. S., Lu, Q., Faucette, L. F., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202925 · Cited by 420 · see citing works
Liu, F., Stanton, J. J., Wu, Z., & Piwnica-Worms, H. M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.571 · Cited by 378 · see citing works
Inactivation of Interferon Regulatory Factor-1 Tumor Suppressor Protein by HPV E7 Oncoprotein
Park, J. S., Kim, E., Kwon, H.-J., Hwang, E.-S., Namkoong, S.-E., & Um, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6764 · Cited by 333 · see citing works
Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53
Mack, D. H., Vartikar, J., Pipas, J. M., & Laimins, L. A. (1993) · Nature · doi:10.1038/363281a0 · Cited by 322 · see citing works
Zwicker, J., Lucibello, F. C., Wolfraim, L. A., Gross, C., Truss, M., Engeland, K., & Müller, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00130.x · Cited by 321 · see citing works
A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells
Downes, C. S., Clarke, D. J., Mullinger, A. M., Giménez-Abián, J. F., Creighton, A. M., & Johnson, R. T. (1994) · Nature · doi:10.1038/372467a0 · Cited by 319 · see citing works
Human Myt1 Is a Cell Cycle-regulated Kinase That Inhibits Cdc2 but Not Cdk2 Activity
Booher, R. N., Holman, P. S., & Fattaey, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22300 · Cited by 313 · see citing works
Kumagai, A., & Dunphy, W. G. (1999) · Genes & Development · doi:10.1101/gad.13.9.1067 · Cited by 303 · see citing works
Evidence for a second cell cycle block at G2/M by p53.
Stewart, N., Hicks, G. G., PARASKEVAS, F., & Mowat, M. R. A. (1995) · PubMed · Cited by 300 · see citing works
Nuclear Localization of Cyclin B1 Controls Mitotic Entry After DNA Damage
Jin, P., Hardy, S. F., & Morgan, D. O. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.875 · Cited by 294 · see citing works
Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DPPreprint
Zheng, N., Fraenkel, E., Pabo, C. O., & Pavletich, N. P. (1999) · Genes & Development · doi:10.1101/gad.13.6.666 · Cited by 271 · see citing works
Control of the G1/S transition.
Reed, S. I. (1997) · PubMed · Cited by 221 · see citing works
Antinore, M. J., Birrer, M. J., Patel, D., Nader, L., & McCance, D. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00546.x · Cited by 211 · see citing works
Mechanisms of G2 Arrest in Response to Overexpression of p53
Taylor, W. R., DePrimo, S. E., Agarwal, A. M., Agarwal, M. L., Schönthal, A. H., Katula, K. S., & Stark, G. R. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.11.3607 · Cited by 195 · see citing works
Self-citationp53 is a general repressor of RNA polymerase III transcription
Cairns, C. A., & White, R. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3112 · Cited by 190 · see citing works
Physiological regulation of eukaryotic topoisomerase II
Isaacs, R. J., Davies, S. L., Sandri, M., Redwood, C. S., Wells, N. J., & Hickson, I. D. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00131-6 · Cited by 186 · see citing works
Meloni, A. R., Smith, E., & Nevins, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9574 · Cited by 183 · see citing works
p53-Mediated Repression of Alpha-Fetoprotein Gene Expression by Specific DNA Binding
Lee, K. C., Crowe, A. J., & Barton, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1279 · Cited by 176 · see citing works
Chang, B.-D., Broude, E. V., Fang, J., Kalinichenko, T. V., Abdryashitov, R. I., Poole, J. C., & Roninson, I. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203573 · Cited by 167 · see citing works
Mitotic DNA damage and replication checkpoints in yeast
Rhind, N., & Russell, P. R. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80118-x · Cited by 164 · see citing works
Tommasi, S., & Pfeifer, G. P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6901 · Cited by 163 · see citing works
p53 Regulation of G <sub>2</sub> Checkpoint Is Retinoblastoma Protein Dependent
Flatt, P. M., Tang, L. J., Scatena, C. D., Szak, S. T., & Pietenpol, J. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4210-4223.2000 · Cited by 161 · see citing works
Ragimov, N., Krauskopf, A., Navot, N., Rotter, V., Oren, M., & Aloni, Y. (1993) · PubMed · Cited by 159 · see citing works
p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor
Yun, J., Chae, H., Choy, H. E., Chung, J., Yoo, H., Han, M.-H., & Shin, D. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29677 · Cited by 155 · see citing works
Inhibition of DNA Topoisomerase IIα Gene Expression by the p53 Tumor Suppressor
Wang, Q., Zambetti, G. P., & Suttle, D. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.389 · Cited by 149 · see citing works
p53 Suppresses the Activation of the Bcl-2 Promoter by the Brn-3a POU Family Transcription Factor
Budhram-Mahadeo, V., Morris, P. J., Smith, M. D., Midgley, C. A., Boxer, L. M., & Latchman, D. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15237 · Cited by 144 · see citing works
The G<sub>2</sub> Checkpoint Is Maintained by Redundant Pathways
Passalaris, T. M., Benanti, J. A., Gewin, L., Kiyono, T., & Galloway, D. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5872 · Cited by 116 · see citing works
Agarwal, M. L., Agarwal, A. M., Taylor, W. R., Chernova, O. B., Sharma, Y., & Stark, G. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14775 · Cited by 110 · see citing works
Self-citationUtrera, R., Collavin, L., Lazarević, D., Delia, D., & Schneider, C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5015 · Cited by 97 · see citing works
Sp1-Mediated Transcription of the Werner Helicase Gene Is Modulated by Rb and p53
Yamabe, Y., Shimamoto, A., Goto, M., Yokota, J., Sugawara, M., & Furuichi, Y. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6191 · Cited by 91 · see citing works
p53 Regulates the Minimal Promoter of the Human Topoisomerase II Gene
Sandri, M., Isaacs, R., Ongkeko, W. M., Harris, A. L., Hickson, I. D., Broggini, M., & Vikhanskaya, F. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.22.4464 · Cited by 91 · see citing works
Serum-Induced Expression of the cdc25A Gene by Relief of E2F-Mediated Repression
Chen, X., & Prywes, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4695 · Cited by 90 · see citing works
Functional analysis of E2F transcription factor
Nevins, J. R., DeGregori, J. V., Jakoi, L., & Leone, G. W. (1997) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(97)83017-0 · Cited by 86 · see citing works
Massimi, P., Pim, D., Storey, A., & Banks, L. (1996) · PubMed · Cited by 85 · see citing works
Regulation of CAK kinase activity by p53
Schneider, E., Montenarh, M., & Wagner, P. (1998) · Oncogene · doi:10.1038/sj.onc.1202504 · Cited by 85 · see citing works
Badie, C., Itzhaki, J. E., Sullivan, M. J., Carpenter, A. J., & Porter, A. C. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2358-2366.2000 · Cited by 83 · see citing works
Leone, G. W., DeGregori, J. V., Jakoi, L., Cook, J. G., & Nevins, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6626 · Cited by 83 · see citing works
p53 inhibits entry into mitosis when DNA synthesis is blocked
Taylor, W. R., Agarwal, M. L., Agarwal, A. M., Stacey, D. W., & Stark, G. R. (1999) · Oncogene · doi:10.1038/sj.onc.1202516 · Cited by 79 · see citing works
Self-citationLiu, N. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.24.4915 · Cited by 76 · see citing works
p53 represses Sp1 DNA binding and HIV-LTR directed transcription.
Bargonetti, J., Chicas, A., White, D., & Prives, C. L. (1997) · PubMed · Cited by 75 · see citing works
Toledo, S. D., Azzam, E. I., Keng, P. C., Laffrenier, S., & Little, J. B. (1998) · PubMed · Cited by 74 · see citing works
Farmer, G. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.21.4281 · Cited by 74 · see citing works
Mimosine Arrests the Cell Cycle after Cells Enter S-Phase
Hughes, T. A., & Cook, P. R. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0035 · Cited by 66 · see citing works
The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited
Chernova, O. B., Chernov, M. V., Agarwal, M. L., Taylor, W. R., & Stark, G. R. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89094-5 · Cited by 66 · see citing works
Self-citationCDC2 is down-regulated by ionizing radiation in a p53-dependent manner.
Azzam, E. I., Toledo, S. D., Pykett, M. J., Nagasawa, H. T., & Little, J. B. (1997) · PubMed · Cited by 53 · see citing works
Sugarman, J. L., Schönthal, A. H., & Glass, C. K. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3282 · Cited by 43 · see citing works
Self-citationDong, F., Cress, W. D., Agrawal, D., & Pledger, W. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6190 · Cited by 42 · see citing works
CHF: a novel factor binding to cyclin A CHR corepressor element
Philips, A., Chambeyron, S., Lamb, N. J. C., Vié, A., & Blanchard, J. M. (1999) · Oncogene · doi:10.1038/sj.onc.1203017 · Cited by 40 · see citing works
The E7 Oncoprotein of Human Papillomavirus Type 16 Interacts with F-Actin in Vitro and in Vivo
Rey, O., Lee, S., Baluda, M. A., Swee, J., Ackerson, B. K., Chiu, R., & Park, N.-H. (2000) · Virology · doi:10.1006/viro.1999.0175 · Cited by 29 · see citing works
Olgiate, J., Ehmann, G. L., Vidyarthi, S., Hilton, M., & Bachenheimer, S. L. (1999) · Virology · doi:10.1006/viro.1999.9755 · Cited by 29 · see citing works
The p53 Tumor Suppressor Inhibits Transcription of the TATA-less Mouse DP1 Promoter
Gopalkrishnan, R. V., Lam, E. W. ‐., & Kédinger, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.10972 · Cited by 26 · see citing works
Linkages of nuclear architecture to biological and pathological control of gene expression
Stein, G. S., van Wijnen, A. J., Stein, J. L., Lian, J. B., Pockwinse, S. M., & McNeil, S. M. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+ · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Regulation of the G2/M transition by p53
Taylor, W. R., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204252 · Cited by 1,553 · see citing works
Self-citationCensus and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971 · see citing works
Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53
Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 794 · see citing works
Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM
Engeland, K. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.172 · Cited by 656 · see citing works
p53 and E2f: partners in life and death
Polager, S., & Ginsberg, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2718 · Cited by 498 · see citing works
Godár, S., Ince, T. A., Bell, G. W., Feldser, D. M., Donaher, J. L., Bergh, J. C. S., Liu, A. Y., Miu, K., Watnick, R. S., Reinhardt, F., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.006 · Cited by 455 · see citing works
Fischer, M., Grossmann, P., Padi, M., & DeCaprio, J. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw523 · Cited by 330 · see citing works
The common and distinct target genes of the p53 family transcription factors
Harms, K. L., Nozell, S. E., & Chen, X. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3304-4 · Cited by 296 · see citing works
Control of the G2/M Transition
Stark, G. R., & Taylor, W. R. (2006) · Molecular Biotechnology · doi:10.1385/mb:32:3:227 · Cited by 279 · see citing works
Self-citationCell cycle transcription control: DREAM/MuvB and RB-E2F complexes.
Fischer, M., & Müller, G. A. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1360836 · Cited by 255 · see citing works
p21/CDKN1A Mediates Negative Regulation of Transcription by p53
Löhr, K., Möritz, C., Contente, A., & Dobbelstein, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212517200 · Cited by 227 · see citing works
CDC20, a potential cancer therapeutic target, is negatively regulated by p53
Kidokoro, T., Tanikawa, C., Furukawa, Y., Katagiri, T., Nakamura, Y., & Matsuda, K. (2007) · Oncogene · doi:10.1038/sj.onc.1210799 · Cited by 208 · see citing works
Direct p53 Transcriptional Repression: In Vivo Analysis of CCAAT-Containing G2/M Promoters
Imbriano, C., Gurtner, A., Cocchiarella, F., Agostino, S. D., Basile, V., Gostissa, M., Dobbelstein, M., Sal, G. D., Piaggio, G., & Mantovani, R. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3737-3751.2005 · Cited by 205 · see citing works
Stark, G. R., & Taylor, W. R. (2004) · Humana Press eBooks · doi:10.1385/1-59259-788-2:051 · Cited by 195 · see citing works
Self-citationPro-proliferative FoxM1 is a target of p53-mediated repression
Barsotti, A. M., & Prives, C. L. (2009) · Oncogene · doi:10.1038/onc.2009.282 · Cited by 166 · see citing works
Zhang, J., Yang, J., Roy, S. K., Tininini, S., Hu, J., Bromberg, J., Poli, V., Stark, G. R., & Kalvakolanu, D. V. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633516100 · Cited by 166 · see citing works
Self-citationDNA Damage-Induced Downregulation of Cdc25C Is Mediated by p53 via Two Independent Mechanisms
Clair, S. S., Giono, L. E., Varmeh, S., Resnick‐Silverman, L., Liu, W.-J., Padi, A., Dastidar, J., DaCosta, A., Mattia, M., & Manfredi, J. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.002 · Cited by 162 · see citing works
Aberrant Regulation of Survivin by the RB/E2F Family of Proteins
Jiang, Y., Saavedra, H. I., Holloway, M. P., Leone, G. W., & Altura, R. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404496200 · Cited by 159 · see citing works
The transcription factor p53: Not a repressor, solely an activator.
Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153 · see citing works
Dynamic Recruitment of NF-Y and Histone Acetyltransferases on Cell-cycle Promoters
Caretti, G., Salsi, V., Vecchi, C., Imbriano, C., & Mantovani, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304606200 · Cited by 153 · see citing works
Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts
Baus, F., Gire, V., Fisher, D., Piette, J., & Dulić, V. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg387 · Cited by 143 · see citing works
Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21Waf1/Cip1
Göke, R., Barth, P. J., Schmidt, A., Samans, B., & Lankat–Buttgereit, B. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00025.2004 · Cited by 135 · see citing works
p53-dependent Down-regulation of Telomerase Is Mediated by p21
Shats, I., Milyavsky, M., Tang, X., Stambolsky, P., Erez, N., Brosh, R., Kogan, I., Braunstein, I., Tzukerman, M., Ginsberg, D., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402502200 · Cited by 133 · see citing works
Cyr61, a Member of CCN Family, Is a Tumor Suppressor in Non-Small Cell Lung Cancer
Tong, X., Xie, D., O'Kelly, J., Miller, C. W., Muller-Tidow, C., & Koeffler, H. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107878200 · Cited by 132 · see citing works
Spurgers, K. B., Gold, D. L., Coombes, K. R., Bohnenstiehl, N. L., Mullins, B., Meyn, R. E., Logothetis, C. J., & McDonnell, T. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513901200 · Cited by 114 · see citing works
Distinct mechanisms act in concert to mediate cell cycle arrest
Toettcher, J. E., Loewer, A., Ostheimer, G. J., Yaffe, M. B., Tidor, B., & Lahav, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806196106 · Cited by 112 · see citing works
G2 arrest in response to topoisomerase II inhibitors: the role of p53.
Clifford, B., Beljin, M., Stark, G. R., & Taylor, W. R. (2003) · PubMed · Cited by 109 · see citing works
Self-citationJackson, J. G., & Pereira-Smith, O. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2501-2510.2006 · Cited by 108 · see citing works
Cell cycle molecules and vertebrate neuron death: E2F at the hub
Greene, L. A., Biswas, S. C., & Liu, D. X. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401341 · Cited by 108 · see citing works
Huang, Y., Liu, N., Liu, J., Liu, Y., Zhang, C., Long, S., Luo, G., Zhang, L., & Zhang, Y. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1688951 · Cited by 94 · see citing works
Jackson, M. W., Agarwal, M. K., Yang, J., Bruss, P., Uchiumi, T., Agarwal, M. L., Stark, G. R., & Taylor (2005) · Journal of Cell Science · doi:10.1242/jcs.02307 · Cited by 92 · see citing works
Self-citationp53 is a NF‐Y‐ and p21‐independent, Sp1‐dependent repressor of cyclin B1 transcription
Innocente, S. A., & Lee, J. M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.12.073 · Cited by 87 · see citing works
p53 Promotes Cell Survival due to the Reversibility of Its Cell-Cycle Checkpoints
Lukin, D. J., Carvajal, L. A., Liu, W.-J., Resnick‐Silverman, L., & Manfredi, J. J. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0177 · Cited by 86 · see citing works
B-MYB Is Required for Recovery from the DNA Damage–Induced G2 Checkpoint in p53 Mutant Cells
Mannefeld, M., Klassen, E., & Gaubatz, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4156 · Cited by 82 · see citing works
Voghel, G., Thorin‐Trescases, N., Farhat, N., Mamarbachi, A. M., Villeneuve, L. R., Fortier, A., Perrault, L. P., Carrier, M., & Thorin, É. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.01.004 · Cited by 81 · see citing works
Rb/E2F4 and Smad2/3 link survivin to TGF-β-induced apoptosis and tumor progression
Yang, J., Song, K. W., Krebs, T. L., Jackson, M. W., & Danielpour, D. (2008) · Oncogene · doi:10.1038/onc.2008.165 · Cited by 76 · see citing works
Basile, V., Mantovani, R., & Imbriano, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507712200 · Cited by 75 · see citing works
Charoensinphon, N., Qiu, P., Dong, P., Zheng, J., Ngauv, P., Cao, Y., Li, S., Ho, C., & Xiao, H. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300136 · Cited by 72 · see citing works
Wild-type p53 and p73 negatively regulate expression of proliferation related genes
Scian, M. J., Carchman, E. H., Mohanraj, L., Stagliano, K. E., Anderson, M. A. E., Deb, D., Crane, B., Kiyono, T., Windle, B. E., Deb, S., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210898 · Cited by 71 · see citing works
Polager, S., & Ginsberg, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210327200 · Cited by 70 · see citing works
Cdc2: A monopotent or pluripotent CDK?
Hu, X., & Moscinski, L. C. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2011.00753.x · Cited by 69 · see citing works
p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers
Zhang, D. W., Jeang, K.-T., & Lee, C. G. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209220 · Cited by 69 · see citing works
Calvisi, D. F., Simile, M. M., Ladu, S., Frau, M., Evert, M., Tomasi, M. L., Demartis, M. I., Daino, L., Seddaiu, M. A., Brozzetti, S., et al. (2011) · Hepatology · doi:10.1002/hep.24174 · Cited by 65 · see citing works
Wang, M., Qanungo, S., Crow, M. T., Watanabe, M., & Nieminen, A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.040 · Cited by 63 · see citing works
E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma
Crosby, M. E., Jacobberger, J. W., Gupta, D., Macklis, R. M., & Almasan, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209998 · Cited by 60 · see citing works
One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor
Böhlig, L., & Rother, K. (2011) · BioMed Research International · doi:10.1155/2011/464916 · Cited by 58 · see citing works
Bhawe, K. M., & Roy, D. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0395-3 · Cited by 57 · see citing works
Gene expression profiles in human cells submitted to genotoxic stress
Sakamoto‐Hojo, E. T., Mello, S. S., Pereira, E. C., Fachin, A. L., Cardoso, R. S., Junta, C. M., Sandrin‐Garcia, P., Donadi, E. A., & Passos, G. A. S. (2003) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2003.07.004 · Cited by 55 · see citing works
Luo, X., Huang, Y., & Sheikh, M. S. (2003) · Oncogene · doi:10.1038/sj.onc.1207010 · Cited by 55 · see citing works
Inhibitory Effects of Metabolites of 5-Demethylnobiletin on Human Nonsmall Cell Lung Cancer Cells
Song, M., Charoensinphon, N., Wu, X., Zheng, J., Gao, Z., Xu, F., Wang, M., & Xiao, H. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b01367 · Cited by 50 · see citing works
A role for p53 in terminal epithelial cell differentiation
Saifudeen, Z. R., Dipp, S., & El-Dahr, S. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13972 · Cited by 49 · see citing works
The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression
Fenouille, N., Robert, G., Tichet, M., Puissant, A., Dufies, M., Rocchi, S., Ortonne, J. P., Deckert, M., Ballotti, R., & Tartare‐Deckert, S. (2010) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00790.x · Cited by 43 · see citing works
Noll, J. E., Vandyke, K., Hewett, D. R., Mrozik, K. M., Bala, R. J., Williams, S. A., Kok, C. H., & Zannettino, A. C. W. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0209-2 · Cited by 43 · see citing works
Transcriptional Repression of Taurine Transporter Gene (TauT) by p53 in Renal Cells
Han, X., Patters, A. B., & Chesney, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205939200 · Cited by 43 · see citing works
Scoumanne, A., & Chen, X. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0121 · Cited by 42 · see citing works
Coordination of Repair, Checkpoint, and Cell Death Responses to DNA Damage
Wang, J. Y. J., & Cho, S. K. (2004) · Advances in protein chemistry · doi:10.1016/s0065-3233(04)69004-8 · Cited by 42 · see citing works
The human 1‐8D gene (IFITM2) is a novel p53 independent pro‐apoptotic gene
Daniel‐Carmi, V., Makovitzki‐Avraham, E., Reuven, E. M., Goldstein, I., Zilkha, N., Rotter, V., Tzehoval, E., & Eisenbach, L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24669 · Cited by 41 · see citing works
A Role for the Fanconi Anemia C Protein in Maintaining the DNA Damage-induced G2 Checkpoint
Freie, B. W., Ciccone, S. L. M., Li, X., Plett, P. A., Orschell, C. M., Srour, E. F., Hanenberg, H., Schindler, D., Lee, S., & Clapp, D. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407160200 · Cited by 40 · see citing works
Song, M., Lan, Y., Wu, X., Han, Y., Wang, M., Zheng, J., Li, Z., Li, F., Zhou, J., Xiao, J., et al. (2020) · Food & Function · doi:10.1039/d0fo00616e · Cited by 38 · see citing works
p53 Inactivation Upregulates p73 Expression through E2F-1 Mediated Transcription
Tophkhane, C., Yang, S., Jiang, Y., Ma, Z., Subramaniam, D., Anant, S., Yogosawa, S., Sakai, T., Liu, W., Edgerton, S. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043564 · Cited by 37 · see citing works
A role for p53 in terminal epithelial cell differentiation
Saifudeen, Z. R., Dipp, S., & El-Dahr, S. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213972 · Cited by 37 · see citing works
Bajaj, S., Alam, S. K., Roy, K. S., Datta, A., Nath, S., & Roychoudhury, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.731398 · Cited by 36 · see citing works
Saddouk, F. Z., Sun, L., Liu, Y. F., Jiang, M., Singer, D. V., Backs, J., Riper, D. A. V., Ginnan, R. G., Schwarz, J. J., & Singer, H. A. (2015) · The FASEB Journal · doi:10.1096/fj.15-279158 · Cited by 33 · see citing works
Studies on radiation-induced apoptosis in G 0 human lymphocytes
Belloni, P., Meschini, R., Czene, S., Harms‐Ringdahl, M., & Palitti, F. (2005) · International Journal of Radiation Biology · doi:10.1080/09553000500303690 · Cited by 31 · see citing works
Transcriptional control of the proliferation cluster by the tumor suppressor p53
Brosh, R., & Rotter, V. (2009) · Molecular BioSystems · doi:10.1039/b911416e · Cited by 30 · see citing works
Zinc-induced G2/M blockage is p53 and p21 dependent in normal human bronchial epithelial cells
Wong, S. H. K., Shih, R. S. M., Schoene, N. W., & Lei, K. Y. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00061.2008 · Cited by 30 · see citing works
Improving the selectivity of cancer treatments by interfering with cell response pathways
Damia, G. L. M., & Broggini, M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.020 · Cited by 28 · see citing works
Kan, C. E., Patton, J. T., Stark, G. R., & Jackson, M. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0259 · Cited by 26 · see citing works
Self-citationRole of p21 in SP600125-induced cell cycle arrest, endoreduplication, and apoptosis
Moon, D., Choi, Y. H., & Kim, G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0626-5 · Cited by 26 · see citing works
Moxley, A. H., & Reisman, D. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3590 · Cited by 24 · see citing works
Exit from Arsenite-Induced Mitotic Arrest Is p53 Dependent
McNeely, S., Xu, X., Taylor, B. F., Zacharias, W., McCabe, M. J., & States, J. C. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8969 · Cited by 23 · see citing works
Bassi, L., Carloni, M., Meschini, R., Fonti, E., & Palitti, F. (2003) · International Journal of Radiation Biology · doi:10.1080/09553000310001632930 · Cited by 23 · see citing works
Regulation of p53-dependent transcription
Jõers, A. (2004) · DSpace repository (University of Tartu) · Cited by 20 · see citing works
Interplay between HMGA and TP53 in cell cycle control along tumor progression
Costa, N. M. D., Palumbo, A., Martino, M. D., Fusco, A., Pinto, L. F. R., & Nasciutti, L. E. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03634-4 · Cited by 20 · see citing works
Ikeda, M., Okamoto, I., Tamura, K., Satoh, T., Yonesaka, K., Fukuoka, M., & Nakagawa, K. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.08.005 · Cited by 15 · see citing works
Brusa, G., Benvenuti, M., Mazzacurati, L., Mancini, M., Pattacini, L., Martinelli, G., Barbieri, E., Greenberger, J. S., Baccarani, M., & Santucci, M. A. (2003) · PubMed · Cited by 14 · see citing works
Functional Analysis of CDK Inhibitor p21WAF1
Fotedar, R., Bendjennat, M., & Fotedar, A. (2004) · Humana Press eBooks · doi:10.1385/1-59259-811-0:055 · Cited by 13 · see citing works
Yoshida, M., Matsui, Y., Iizuka, A., & Ikarashi, Y. (2009) · PubMed · Cited by 12 · see citing works
P130 and its truncated form mediate p53-induced cell cycle arrest inRb−/− Saos2 cells
Gao, C.-F., Ren, S., Wang, J., Zhang, S.-L., Jin, F., Nakajima, T., Ikeda, M., & Tsuchida, N. (2002) · Oncogene · doi:10.1038/sj.onc.1205933 · Cited by 12 · see citing works
Rakotopare, J., Lejour, V., Duval, C. J., Eldawra, E., Escoffier, H., & Toledo, F. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050376 · Cited by 14 · see citing works
Zhang, J., Wang, S., Kern, S. J., Cui, X., & Danner, R. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607609200 · Cited by 11 · see citing works
Ma, X., Fan, M., Yang, K., Wang, Y., Hu, R., Guan, M., Hou, Y., Ying, J., Deng, N., Li, Q., et al. (2023) · Cancer Science · doi:10.1111/cas.15947 · Cited by 10 · see citing works
Targeting the Cell Cycle to Kill Cancer Cells
Taylor, W. R., & Grabovich, A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369521-5.00017-8 · Cited by 9 · see citing works
Self-citationMukherjee, J. J., & Kumar, S. (2013) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2013.05.009 · Cited by 8 · see citing works
Vikhanskaya, F., & Broggini, M. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)19013-9 · Cited by 8 · see citing works
Pei, J., Zhou, S., Yang, F., Sun, Y., Li, A., Zhang, W., & He, W. (2016) · Chemistry - An Asian Journal · doi:10.1002/asia.201600714 · Cited by 7 · see citing works
A role for p53 in terminal epithelial cell differentiation
Saifudeen, Z. R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200213972 · Cited by 7 · see citing works
Bird, R. C., & DeInnocentes, P. (2004) · PubMed · Cited by 6 · see citing works
Huynh, H. T., Nguyen, T., Panasci, L., & Do, P. (2004) · Cancer · doi:10.1002/cncr.20670 · Cited by 5 · see citing works
Mechanisms of G2 Phase Arrest in DNA Damage-Induced Checkpoint Response
Kuang, J., & Wang, R. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_3 · Cited by 3 · see citing works
Transactivation of Human cdc2 Promoter by Adenovirus E1A
Padmanabhan, R., Tanimoto, A., & Sasaguri, Y. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05597-7_12 · Cited by 2 · see citing works
Hung, H., Chow, P. K. H., Soo, K. C., Panasci, L. C., & Hung, N. T. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20336 · Cited by 2 · see citing works
Research progress on cell cycle arrest in dermal fibroblasts
Wu, M., Luo, J., Yang, W., Wei, Z., Li, Y., & Pan, X. (2025) · Cell Cycle · doi:10.1080/15384101.2025.2557240 · Cited by 1 · see citing works
Alwadi, D., Felty, Q. H., Doke, M., Roy, D., Yoo, C., & Deoraj, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125463 · Cited by 1 · see citing works
Treatment-Induced Tumor Cell Senescence and Its Consequences
Broude, E. V. (2008) · CRC Press eBooks · doi:10.3109/9781420020502-15 · Cited by 1 · see citing works
Vaccinia virus modulates the host cell cycle to promote infection
Martin, C. K. (2019) · UCL Discovery (University College London) · Cited by 1 · see citing works
G2 Phase Cell Cycle Regulation by E2F4 Following Genotoxic Stress
Crosby, M. E. (2006) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1 · see citing works
Signaling in natural killer cells: SHIP, 2B4 and the Kinome
Wahle, J. A. (2007) · Digital Commons - University of South Florida (University of South Florida)
Morisaki, H., Kurihara, K., Haseba, Y., Takahashi, M., & Igarashi, T. (2005) · Shōwa Shigakkai zasshi/Showa Shigakkai zasshi · doi:10.11516/dentalmedres1981.25.161
- Authors
- Taylor, W. R., Schönthal, A. H., Galante, J., & Stark, G. R.
- Affiliations
- Cleveland Clinic (US)
- University of Southern California (US)
- Corresponding author
- Stark, George R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-01
- Volume
- 276
- Issue
- 3
- Pages
- 1998-2006
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2086565810
- Cited by
- 110
- References
- 89
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 3 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 2
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM49345, R01GM049345)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- p53, transcriptional repression, p21, cyclin-dependent kinases, G2 cell cycle arrest, E2F4, cyclin B1
- MeSH terms
- Base Sequence, Cell Line, DNA, DNA-Binding Proteins, Molecular Sequence Data, Promoter Regions, Genetic, Protein Binding, Repressor Proteins, Transcription Factors, Transcription, Genetic, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cyclin-Dependent Kinases, CDC2-CDC28 Kinases, E2F4 Transcription Factor, Cyclin-Dependent Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review